Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 8—August 2004
Research

Crimean-Congo Hemorrhagic Fever in Turkey

S. Sami Karti*Comments to Author , Zekaver Odabasi†, Volkan Korten†, Mustafa Yilmaz*, Mehmet Sonmez*, Rahmet Caylan*, Elif Akdogan*, Necmi Eren*, Iftihar Koksal*, Ercument Ovali*, Bobbie R. Erickson‡, Martin J. Vincent‡, Stuart T. Nichol‡, James A. Comer‡, Pierre E. Rollin‡, and Thomas G. Ksiazek‡
Author affiliations: *Karadeniz Technical University, School of Medicine, Trabzon, Turkey; †Marmara University School of Medicine, Istanbul, Turkey; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table

Signs and symptoms among clinically suspected and confirmed CCHF patientsa

Signs and symptoms
Confirmed cases n=5 Suspected cases n=14 Total (%) n=19
Malaise
5
14
19 (100%)
Fever
4
12
16 (84%)
Nausea and vomiting
3
13
16 (84%)
Abdominal pain
3
13
16 (84%)
Petechiae-ecchymosis
5
6
11 (58%)
Myalgia
4
4
8 (42%)
Bleeding from various sites
1
7
8 (42%)
Diarrhea
3
4
7 (37%)
Lymphadenopathy
1
3
4 (21%)
Hepatomegaly 1 3 4 (21%)

aCCHF, Crimean-Congo hemorrhagic fever.

Main Article

Page created: March 01, 2011
Page updated: March 01, 2011
Page reviewed: March 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external